Építés alatt – nem éles oldal
Belépés
Visszavonva1. fázis

Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease

A legfontosabb adatok

Ki végzi
University of Alabama at Birmingham
Hol
Birmingham (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Visszavonva
Fázis
1. fázis
Kezdés
2024. jan. 31.
Várható befejezés
2029. jún. 30.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • UKidney
A regiszteradat frissítve
2024. február 1.
Miért állt le
Approval to move forward with this clinical trial has not been granted by governing bodies.

Ki vehet részt

Életkor
18 év – 75 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 25 feltétel megnézéseKevesebb

Ki vehet részt

  • Ages 18-75 years
  • Body mass index (BMI) 18-40 kg/m2
  • Waitlisted for kidney allotransplantation at UAB
  • Dialysis dependent
  • Proficient in the English language
  • Presence of risk factors for; high wait list mortality, AND/OR; anticipated or actual prolonged wait time on the wait list, AND/OR; inability to access a suitable organ offer; Note: Examples of risk factors include high cPRA, frequent incompatible crossmatches leading to prolonged wait times, listing at an advanced age, and impending loss of dialysis access, recurrent disease in previous transplants
  • Crossmatch compatible with porcine donor
  • SARS-CoV-2 vaccination in accordance with most recent CDC guidance
  • Willingness to obtain other standard-of-care vaccinations for kidney transplant recipients (MMR, HBV, Herpes Zoster, etc.) and for patients receiving eculizumab (Menactra® and Bexsero®)
  • Reside within a 60-minute radius of the UAB hospital (by ground transport)

Ki nem vehet részt

  • Current use/abuse of illicit drugs and/or abuse of alcohol
  • Pre-emptive transplant
  • Presence of hypercoagulable disorder
  • History of medical non-compliance
  • Presence of untreated psychiatric disease
  • History of psychiatric hospitalization
  • Presence of severe comorbid disease, including but not limited to uncontrolled HTN or DM (hemoglobin A1C (HgA1C) >10%), advanced cardiovascular disease, absent surgical targets for implantation, etc
  • Age <18y or ≥ 76y
  • BMI ≤ 18 or ≥ 41 kg/m2
  • Current pregnancy
  • Inability to accept a blood transfusion
  • Intolerance of immunosuppression
  • Significant psychosocial vulnerability and/or poor social support
  • Inability to provide informed consent
  • Inability to comply with study protocols and procedures

Helyszínek itt: Egyesült Államok

  • University of Alabama BirminghamBirmingham, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The mismatch between organ supply and demand results in the deaths of thousands of Americans each year. Our research group aims to solve this unmitigated health care crisis by translating advances in xenotransplantation to humans and expanding organ supply in a sustainable fashion using genetically modified pigs as a source of organs. We propose here a phase I clinical trial of porcine kidney xenotransplantation into 20 people with end-stage kidney disease. Source donor animals are pigs with 10 gene edits (10-GE) which attenuate immunologic harm to the kidney xenograft. 10-GE pigs are housed in a designated pathogen-free facility within 30 minutes of the transplantation center. Xenotransplantation procedures follow conventional practices currently employed in allotransplantation and comply with multiple regulatory standards to ensure ethical treatment of research subjects and source animals. Recruitment and xenotransplantation will occur over 5 years with study follow-up extending 1 year after xenotransplantation. Primary outcome variables surround patient safety, such as patient survival and the rate of zoonotic disease transmission. Secondary outcome variables include commonly used metrics of graft survival and function.

A vizsgálat csoportja

  • Porcine Kidney (UKidney) transplantA vizsgált kezelés

    In this phase I single arm study patients with acute renal failure will be transplanted with a porcine xenograft versus a human allograft-after transplantation the best practice standard of care will be followed for monitoring and immunosuppression with the exception of additional monitoring for potential porcine transmitted infections

    Kezelés: UKidney

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2024. február 1.